Manandhar M S, Thomas J A
Invest Urol. 1976 Jul;14(1):20-2.
When homogenates of rat ventral prostate glands were incubated with varying amounts of prolactin (0.2, 0.8, or 2.0 IU per ml), there were significant alterations in the bioconversion of [3H]testosterone and its principal radiometabolites. A 2.0-IU per ml dose of prolactin significantly reduced the metabolism of labeled testosterone in the prostate gland (P less than or equal to 0.01). Similarly, the amounts of [3H]5alpha-androstane-3beta,-17beta-diol ([3H]androstanediol) formed from [3H]testosterone were significantly lower (P less than or equal to 0.05) in the prolactin-treated groups than they were in the controls. Only the highest dose of prolactin (namely, 2.0 IU per ml) impaired the conversion of [3H]testosterone to [3H]17beta-hydroxy-5alpha-androstan-3-one and to [3H]-dihydrotestosterone in the homogenates of rat ventral prostate glands. These findings suggest that prolactin is capable of exerting intracellular actions as evidenced by its ability to interfere with steroidogenesis in androgen-dependent tissues.
当用不同量的催乳素(每毫升0.2、0.8或2.0国际单位)孵育大鼠腹侧前列腺匀浆时,[3H]睾酮及其主要放射性代谢产物的生物转化发生了显著变化。每毫升2.0国际单位剂量的催乳素显著降低了前列腺中标记睾酮的代谢(P≤0.01)。同样,在催乳素处理组中,由[3H]睾酮形成的[3H]5α-雄甾烷-3β,-17β-二醇([3H]雄甾二醇)的量显著低于对照组(P≤0.05)。只有最高剂量的催乳素(即每毫升2.0国际单位)会损害大鼠腹侧前列腺匀浆中[3H]睾酮向[3H]17β-羟基-5α-雄甾烷-3-酮和[3H]-双氢睾酮的转化。这些发现表明,催乳素能够发挥细胞内作用,这一点可通过其干扰雄激素依赖性组织中类固醇生成的能力得到证明。